Clinical trial
A Randomised Controlled Trial of Nitric Oxide Administration During Cardiopulmonary Bypass in Infants Undergoing Arterial Switch Operation for Repair of Transposition of the Great Arteries
NCT03661385 is registered in ClinicalTrials.gov with Murdoch Childrens Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised Controlled Trial of Nitric Oxide Administration During Cardiopulmonary Bypass in Infants Undergoing Arterial Switch Operation for Repair of Transposition of the Great Arteries
- Lead sponsor
- Murdoch Childrens Research Institute
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 11, 2018
- Completion date
- April 23, 2023
- Enrollment
- 300 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
low cardiac output syndrome, transposition of great vessels